Somatus Enhances Predictive Capabilities and Risk Accuracy Through Acquisition of Lumiata
Summary
MCLEAN, Va.--(BUSINESS WIRE)--Somatus, the nation’s leading and largest value-based kidney care company, today announced it has acquired strategic assets from Lumiata, a healthcare-specific AI platform. With this acquisition, Somatus will enhance existing capabilities by leveraging Lumiata’s proven ability to accurately predict high-cost claimants and likelihood of disease progression, further advancing the Company’s ability to reduce costs for provider and health plan partners. “Somatus’ and Lumiata’s analytic capabilities and disciplines complement one another in ways that will drive even stronger healthcare outcomes for the kidney care industry,” said Lumiata’s Acting CEO and Chief Operating Officer, Jessica McCarthy, who is joining Somatus as Senior Vice President of Growth Analytics. As the market leader in value-based kidney care, Somatus vertically integrated clinical services and technology delay or prevent disease progression, improve quality and care coordination, and increase the use of home dialysis modalities and rates of kidney transplantation. The company is headquartered in McLean, Virginia, and founded by a team of world-class healthcare operators, successful entrepreneurs, and leading clinicians treating kidney disease.
Classifications
AskAI Classifications
LabelsLinked Companies
